meia

Influencing Factors in Determination of Whole Blood FK506 Level by MEIA

微粒子酶免疫检测法测定血中FK506浓度的影响因素

Conclusion In quantitative detection , MEIA method was more precise than ELISA method .

结论定量检测时，MEIA法比ELISA法更精确；

Comparison of MEIA method and ELISA method in the detection of anti-HCV antibody

MEIA法与ELISA法检测丙型肝炎病毒抗体结果比较

Determination of whole blood concentration of tacrolimus drug with MEIA

微粒子酶免疫法测定他可莫司的血药浓度

Study on Clinical Significance of Serum β - HCG Determined with MEIA in Pregnancy Associated Diseases

微粒子酶免疫法检测血清β-HCG在妊娠相关疾病鉴别诊断中的临床意义

Calibration in Squamous Cell Carcinoma Antigen Assay by MEIA and CLIA

MEIA法和CLIA法检测鳞状细胞癌抗原的标定问题探讨

Significance of MEIA in detection of special HBV-markers patterns

MEIA在检测HBV标志物特殊表达模式中的意义

Objective To evaluate the applications of the MEIA and colloidal gold assay for β - HCG .

目的评价微粒子酶免化学发光法和免疫胶体金试纸法检测β-HCG的方法优劣。

Comparison on two methods of HPLC-MS / MS and MEIA in monitoring the tacrolimus concentrations for organ transplantation patients

HPLC-MS/MS法与MEIA法在监测器官移植患者他克莫司全血浓度中的比较

Methods ELISA and MEIA methods were used to detect total anti-HAV antibody , and compare their sensitivity and accordance .

方法用ELISA和MEIA法检测血清甲肝总抗体，再进行两种方法的互相比较。

Aim To evaluate the accuracy of detecting Tacrolimus concentration in whole blood by MEIA and its clinical application in organ transplantation .

目的评价微粒子酶免（MEIA）法检测全血普乐可复浓度的准确性及其在器官移植术后抗排异治疗中的应用。

The total and the isolated anti-HBc positive rate by MEIA were 78.1 % and 13.2 % , respectively .

MEIA检测抗-HBc的总抗-HBc阳性率及单项抗-HBc阳性率分别为78.1%、13.2%；

Serum CA_ ( 125 ) and CA_ ( 19-9 ) levels were determined with MEIA .

采用微粒子酶免分析法（MEIA）分别检测受试者血清CA125，CA19-9水平。

Comparison of the MEIA and HPLC assays for the measurement of rapamycin concentration in blood of recipients after renal transplantation

微粒子酶联免疫方法和高效液相色谱法测定肾移植受者雷帕霉素血药浓度的比较

The plasma levels of CEA and CA19-9 were determined by microparticle enzyme-linked immunoassay ( MEIA ) before operation .

微粒子酶联免疫荧光法（MEIA）检测大肠癌患者术前血浆CEA、CA19-9水平。

The levels of anti-HBs were analysed in 167 five-HBV-marker negative and 124 anti-HBc-only positive subjects determined for five HBV markers by MEIA .

对MEIA检测的124例单项抗-HBc阳性和167例HBV标志物全阴性住院患者的抗-HBs水平进行分析；

When qualitative detection , positive cases of ELISA and MEIA methods were 39 cases vs 40 cases , then two methods ' coincidence rates are 97.56 % ( 40 / 41 ) .

定性检测时，41例标本中ELISA法检测39例阳性，MEIA法40例阳性，两法的符合率为97.56%（40/41）。

Methods The serum E 2 levels were measured by the microparticle enzyme immunoassay ( MEIA ) in 26 infertile women before and after receiving induced ovulation therapy .

方法应用微粒子酶免（MEIA）法检测26例不孕妇女接受超促排卵治疗前、后的血清E2水平；

Objective To evaluate the clinical significance of the detection of carbohydrate antigen 19 9 ( CA19 9 ) by microparticle enzyme immunoassay ( MEIA ) .

目的评价微粒子捕捉酶免疫法检测糖链抗原199（CA199）的临床应用价值。

In qualitative detection , the ELISA method can objectively reflect the immunogenicity and the protection efficacy of HAV vaccine , as combined to MEIA method its sensitivity can be greatly enhanced .

定性检测时，ELISA法试剂盒能客观反映疫苗的免疫原性和保护效果，与MEIA法结合能大大提高敏感性。

Conclusion To detect HBV markers in serum , TRFIA offers many benefits in sensitivity , specificity , accuracy and practicability , and may be a routine method instead of MEIA and ELISA .

结论TRFIA技术检测HBV血清标志物灵敏度高、特异性强，可替代MEIA和ELISA而成为一种常规检测方法。

Aim To establish a microparticle enzyme immunoassay ( MEIA ) for determination of mecobalamin in serum and to compare the relative bioequivalence of domestic and imported mecobalamin .

目的建立血清中甲钴胺的血药浓度测定方法，比较国产甲钴胺胶囊和进口甲钴胺片在健康人体内的相对生物等效性。

Methods Patients were divided into 3 groups according to HBV markers determined by microparticle enzyme immunoassay ( MEIA ): HBsAg + , HBeAg + , HBcAb + ( group A );

方法根据微粒子酶免疫法（MEIA）检测乙型肝炎病毒（HBV）感染血清学标志的结果分为：A组，HBsAg、HBeAg、HBcAb阳性；

Methods The MEIA was used to detect Tacrolimus valley point concentrations in 6 heart transplanted , 2 liver transplanted , 2 small intestine transplanted and 7 kidney transplanted recipients at different postoperative periods .

方法以MEIA法检测6例心脏移植、2例肝脏移植、2例小肠移植和7例肾脏移植患者不同时期全血中普乐可复的谷浓度，并结合临床情况调整普乐可复的用药剂量。

Method : The serum SCCAg levels were measured by microparticle enzyme immunoassay ( MEIA ) in 46 patients with laryngeal squamous cell carcinoma . Forty one patients with laryngeal benign disease were used as control .

方法：采用微粒子酶免疫法（MicroparticleEnzymeImmunoassay，MEIA）检测46例喉鳞状细胞癌患者血清SCCAg的水平，以41例喉部良性疾病患者作为对照。

To investigate quantitative analysis of HBVM , HBV DNA and their clinical sense in children with hepatitis B. HBVM and HBV DNA were detected by microparticle enzyme immunoassay ( MEIA ) and PCR respectively .

了解小儿乙型肝炎HBVM与HBVdna含量之间的关系及临床意义。采用微粒子酶免分析法（MEIA）检测HBVM，PCR法检测HBVdna。

Methods : Whole blood trough concentration of FK506 was analyzed by microparticle enzyme immunoassay ( MEIA ) . The treatment window trough concentration of FK506 was reviewed by clinical curative effect and adverse drug reaction ( ADR ) of patients .

方法应用微粒子酶免疫分析法（MEIA）测定6例心脏移植受者口服FK506后全血谷浓度，以FK506谷浓度结合病人临床疗效及不良反应的情况，总结FK506在心脏移植术后的治疗窗。

Methods Antibody to thyroglobulin ( TGAb ) and antibody to thyroid-peroxidase ( TPOAb ) were measured in 86 cases of subclinical hyperthyroidism by microparticle enzyme immunoassay ( MEIA ), control group was composed of 51 healthy people .

方法以51名健康人为对照，对86例亚临床甲亢患者用微粒子酶免疫法（MEIA）测定甲状腺球蛋白抗体（TGAb）和甲状腺过氧化物酶抗体（TPOAb）。

Methods The levels of serum total PSA , free PSA and the proportion of free PSA to total PSA was studied in 135 patients with prostate cancer and 117 patients with benign prostatic hyperplasia ( BPH ), using microparticle enzyme-immunoassay ( MEIA ) .

方法用微粒子酶免法对135例前列腺癌和117例前列腺增生（BPH）患者的血清总PSA、游离PSA及游离/总前列腺抗原百分比（F/T百分比）进行比较。

Methods : MEIA was used to detect the maternal serum markers of 3,000 women with second trimester gestation-a - fetoprotein ( AFP ) , free B-chorionic gonadotropin ( B - hCG ) , in order to prenatal screen for Down syndrome .

方法：采用磁性分离酶免疫测定技术检测3000例孕中期母血清标记物&甲胎蛋白（AFP）、游离β-绒毛促性腺激素（β-hCG），筛查唐氏综合征胎儿。